748 related articles for article (PubMed ID: 20644148)
1. Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study.
Takano R; Misu T; Takahashi T; Sato S; Fujihara K; Itoyama Y
Neurology; 2010 Jul; 75(3):208-16. PubMed ID: 20644148
[TBL] [Abstract][Full Text] [Related]
2. Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: an astrocytic damage marker.
Misu T; Takano R; Fujihara K; Takahashi T; Sato S; Itoyama Y
J Neurol Neurosurg Psychiatry; 2009 May; 80(5):575-7. PubMed ID: 19372295
[TBL] [Abstract][Full Text] [Related]
3. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.
Misu T; Fujihara K; Kakita A; Konno H; Nakamura M; Watanabe S; Takahashi T; Nakashima I; Takahashi H; Itoyama Y
Brain; 2007 May; 130(Pt 5):1224-34. PubMed ID: 17405762
[TBL] [Abstract][Full Text] [Related]
4. Neuromyelitis optica and astrocytic damage in its pathogenesis.
Fujihara K
J Neurol Sci; 2011 Jul; 306(1-2):183-7. PubMed ID: 21396661
[TBL] [Abstract][Full Text] [Related]
5. [Neuromyelitis optica and anti-aquaporin 4 antibody--an overview].
Misu T; Fujihara K; Itoyama Y
Brain Nerve; 2008 May; 60(5):527-37. PubMed ID: 18516975
[TBL] [Abstract][Full Text] [Related]
6. [New insights into the pathogenesis of neuromyelitis optica].
Misu T; Takahashi T; Nishiyama S; Takano R; Nakashima I; Fujihara K; Itoyama Y
Brain Nerve; 2010 Sep; 62(9):921-31. PubMed ID: 20844303
[TBL] [Abstract][Full Text] [Related]
7. A prominent elevation of glial fibrillary acidic protein in the cerebrospinal fluid during relapse in neuromyelitis optica.
Takano R; Misu T; Takahashi T; Izumiyama M; Fujihara K; Itoyama Y
Tohoku J Exp Med; 2008 May; 215(1):55-9. PubMed ID: 18509235
[TBL] [Abstract][Full Text] [Related]
8. High CSF neurofilament heavy chain levels in neuromyelitis optica.
Miyazawa I; Nakashima I; Petzold A; Fujihara K; Sato S; Itoyama Y
Neurology; 2007 Mar; 68(11):865-7. PubMed ID: 17353477
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of serum S100B as a marker for the acute phase of aquaporin-4 autoimmune syndrome.
Fujii C; Tokuda T; Ishigami N; Mizuno T; Nakagawa M
Neurosci Lett; 2011 Apr; 494(1):86-8. PubMed ID: 21371524
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid levels of iodothyronines and nerve growth factor in patients with multiple sclerosis and neuromyelitis optica.
Jiang Y; Yang Y; Zhang B; Peng F; Bao J; Hu X
Neuro Endocrinol Lett; 2009 Mar; 30(1):85-90. PubMed ID: 19300400
[TBL] [Abstract][Full Text] [Related]
11. [Neuromyelitis optica and anti-aquaporin 4 antibody--distinct from multiple sclerosis].
Misu T; Takahashi T; Nakashima I; Fujihara K; Itoyama Y
Rinsho Byori; 2009 Mar; 57(3):262-70. PubMed ID: 19363997
[TBL] [Abstract][Full Text] [Related]
12. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.
Takahashi T; Fujihara K; Nakashima I; Misu T; Miyazawa I; Nakamura M; Watanabe S; Shiga Y; Kanaoka C; Fujimori J; Sato S; Itoyama Y
Brain; 2007 May; 130(Pt 5):1235-43. PubMed ID: 17449477
[TBL] [Abstract][Full Text] [Related]
13. Serum GFAP levels in optic neuropathies.
Storoni M; Verbeek MM; Illes Z; Marignier R; Teunissen CE; Grabowska M; Confavreux C; Plant GT; Petzold A
J Neurol Sci; 2012 Jun; 317(1-2):117-22. PubMed ID: 22410258
[TBL] [Abstract][Full Text] [Related]
14. Neuromyelitis optica: a demyelinating disease characterized by acute destruction and regeneration of perivascular astrocytes.
Parratt JD; Prineas JW
Mult Scler; 2010 Oct; 16(10):1156-72. PubMed ID: 20823059
[TBL] [Abstract][Full Text] [Related]
15. CSF high-mobility group box 1 is associated with intrathecal inflammation and astrocytic damage in neuromyelitis optica.
Uzawa A; Mori M; Masuda S; Muto M; Kuwabara S
J Neurol Neurosurg Psychiatry; 2013 May; 84(5):517-22. PubMed ID: 23255728
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of IgG-NMO autoantibodies on S100Beta protein and disability in relapsing neuromyelitis optica.
Robinson-Agramonte MA; Gonçalves CA; Portela LV; Saiz-Hinarejos A; Oses JP; Motta LS; Muller AP; Marquez Gonzalez ME; Souza DO
Neuroimmunomodulation; 2010; 17(3):177-9. PubMed ID: 20134196
[TBL] [Abstract][Full Text] [Related]
17. Neuromyelitis optica lesions may inform multiple sclerosis heterogeneity debate.
Brück W; Popescu B; Lucchinetti CF; Markovic-Plese S; Gold R; Thal DR; Metz I
Ann Neurol; 2012 Sep; 72(3):385-94. PubMed ID: 23034911
[TBL] [Abstract][Full Text] [Related]
18. Serum- and CSF-concentrations of brain specific proteins in hydrocephalus.
Beems T; Simons KS; Van Geel WJ; De Reus HP; Vos PE; Verbeek MM
Acta Neurochir (Wien); 2003 Jan; 145(1):37-43. PubMed ID: 12545260
[TBL] [Abstract][Full Text] [Related]
19. [AQP4 immunohistochemistry in neuromyelitis optica and multiple sclerosis: a neuropathological review].
Yoshida M
Brain Nerve; 2010 Sep; 62(9):961-74. PubMed ID: 20844307
[TBL] [Abstract][Full Text] [Related]
20. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.
Roemer SF; Parisi JE; Lennon VA; Benarroch EE; Lassmann H; Bruck W; Mandler RN; Weinshenker BG; Pittock SJ; Wingerchuk DM; Lucchinetti CF
Brain; 2007 May; 130(Pt 5):1194-205. PubMed ID: 17282996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
